Cargando…
MMRF-CoMMpass Data Integration and Analysis for Identifying Prognostic Markers
Multiple Myeloma (MM) is the second most frequent haematological malignancy in the world although the related pathogenesis remains unclear. The study of how gene expression profiling (GEP) is correlated with patients’ survival could be important for understanding the initiation and progression of MM...
Autores principales: | Settino, Marzia, Arbitrio, Mariamena, Scionti, Francesca, Caracciolo, Daniele, Di Martino, Maria Teresa, Tagliaferri, Pierosandro, Tassone, Pierfrancesco, Cannataro, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7304035/ http://dx.doi.org/10.1007/978-3-030-50420-5_42 |
Ejemplares similares
-
Correlation of changes in subclonal architecture with progression in the MMRF CoMMpass study
por: Kaur, Gurvinder, et al.
Publicado: (2022) -
DMET(TM) Genotyping: Tools for Biomarkers Discovery in the Era of Precision Medicine
por: Agapito, Giuseppe, et al.
Publicado: (2020) -
Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats
por: Di Martino, Maria Teresa, et al.
Publicado: (2020) -
Risk Alleles for Multiple Myeloma Susceptibility in ADME Genes
por: Scionti, Francesca, et al.
Publicado: (2022) -
Pharmacogenomics Biomarker Discovery and Validation for Translation in Clinical Practice
por: Arbitrio, Mariamena, et al.
Publicado: (2020)